Showing results (1-10 of 101) with videos related to
Sort By:
Pageof 11
Biomolecules|June 24, 2022
An Update on CFTR Drug Discovery: Opportunities and ChallengesPasqualina D'Ursi, Paola FossaJournal of Molecular Modeling|August 2, 2011
Docking-based 3D-QSAR analyses of pyrazole derivatives as HIV-1 non-nucleoside reverse transcriptase inhibitorsElena Cichero, Paola FossaBioorganic & Medicinal Chemistry|May 23, 2015
In silico evaluation of human small heat shock protein HSP27: homology modeling, mutation analyses and docking studiesPaola Fossa, Elena CicheroJournal of Molecular Modeling|October 6, 2010
3,4,5-Trisubstituted-1,2,4-4H-triazoles as WT and Y188L mutant HIV-1 non-nucleoside reverse transcriptase inhibitors: docking-based CoMFA and CoMSIA analysesElena Cichero, Laura Buffa, Paola FossaJournal of Enzyme Inhibition and Medicinal Chemistry|October 22, 2011
Docking-based CoMFA and CoMSIA analyses of tetrahydro-β-carboline derivatives as type-5 phosphodiesterase inhibitorsElena Cichero, Olga Bruno, Paola FossaJournal of Molecular Modeling|February 23, 2010
CoMFA and CoMSIA analyses on 1,2,3,4-tetrahydropyrrolo[3,4-b]indole and benzimidazole derivatives as selective CB2 receptor agonistsElena Cichero, Sara Cesarini, Luisa Mosti, et al.Molecular Diversity|August 21, 2015
New insights into PDE4B inhibitor selectivity: CoMFA analyses and molecular docking studiesSara Guariento, Olga Bruno, Paola Fossa, et al.Journal of Molecular Modeling|October 8, 2009
CoMFA and CoMSIA analyses on 4-oxo-1,4-dihydroquinoline and 4-oxo-1,4-dihydro-1,5-, -1,6- and -1,8-naphthyridine derivatives as selective CB2 receptor agonistsElena Cichero, Sara Cesarini, Luisa Mosti, et al.Journal of Computer-Aided Molecular Design|August 21, 2003
In silico rationalization of the structural and physicochemical requirements for photobiological activity in angelicine derivatives and their heteroanaloguesFabrizio Giordanetto, Paola Fossa, Giulia Menozzi, et al.Medicinal Chemistry (Shariqah (United Arab Emirates))|November 6, 2020
Exploring the Selectivity Profile of Sigma Receptor Ligands by Molecular Docking and Pharmacophore AnalysesGiada Righetti, Michele Tonelli, Paola Fossa, et al.Pageof 11